Protalix BioTherapeutics (PLX) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 9,078.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,078.91% |
| Dec 31, 2025 | 113.81% |
| Sep 30, 2025 | -117.34% |
| Jun 30, 2025 | 58.65% |
| Mar 31, 2025 | -108.21% |
| Dec 31, 2024 | -336.80% |
| Sep 30, 2024 | 187.99% |
| Jun 30, 2024 | -124.96% |
| Mar 31, 2024 | -77.57% |
| Dec 31, 2023 | -49.31% |
| Sep 30, 2023 | -1,466.99% |
| Jun 30, 2023 | 316.95% |
| Mar 31, 2023 | 172.29% |
| Dec 31, 2022 | -77.33% |
| Sep 30, 2022 | 92.38% |
| Jun 30, 2022 | -149.79% |
| Mar 31, 2022 | -1,483.83% |
| Dec 31, 2021 | 502.96% |
| Sep 30, 2021 | -368.03% |
| Jun 30, 2021 | 250.06% |
| Mar 31, 2021 | 144.47% |
| Dec 31, 2020 | 228.32% |
| Sep 30, 2020 | 336.20% |
| Jun 30, 2020 | -77.91% |
| Mar 31, 2020 | 53.07% |
| Dec 31, 2019 | 6.68% |
| Sep 30, 2019 | -127.37% |
| Jun 30, 2019 | 34.86% |
| Mar 31, 2019 | 21.50% |
| Dec 31, 2018 | -122.18% |
| Sep 30, 2018 | 1,191.21% |
| Jun 30, 2018 | 39.76% |
| Mar 31, 2018 | 37.39% |
| Dec 31, 2017 | 46.00% |
| Sep 30, 2017 | 64.87% |
| Jun 30, 2017 | -8.08% |
| Mar 31, 2017 | -62.71% |
| Dec 31, 2016 | -70.23% |
| Sep 30, 2016 | 65.28% |
| Jun 30, 2016 | -169.77% |
| Mar 31, 2016 | -52.59% |
| Mar 31, 2015 | 27.80% |
| Mar 31, 2014 | 15.53% |
| Dec 31, 2013 | -0.25% |
| Sep 30, 2013 | 748.59% |
| Jun 30, 2013 | -163.65% |
| Mar 31, 2013 | -155.72% |
| Dec 31, 2012 | 121.50% |
| Sep 30, 2012 | 2.00% |
| Jun 30, 2012 | 320.48% |
| Mar 31, 2012 | 28.98% |
| Dec 31, 2011 | 16.19% |
| Sep 30, 2011 | 16.11% |